FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease

29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...

Read more →

Bot Image receives FDA clearance for artificial intelligence software used in detection and diagnosis of prostate cancer

8 August 2022 - Bot Image has developed an AI driven medical device CAD software to significantly improve the accuracy and ...

Read more →

Pear Therapeutics and SelectHealth announce coverage to provide access to FDA authorised prescription digital therapeutic for the treatment of opioid use disorder

8 August 2022 - SelectHealth teams with Pear to provide its members with covered access to Pear’s innovative prescription digital therapeutic, ...

Read more →

PhRMA’s Ubl calls Senate passage of partisan drug pricing plan a “tragic loss for patients”

7 August 2022 - PhRMA President and CEO Stephen J. Ubl released the following statement after the U.S. Senate passed ...

Read more →

Lurbinectedin receives the Innovative Medicine designation by the UK’s MHRA

5 August 2022 - PharmaMar has announced today that Zepzelca (lurbinectedin) has received the Innovation Passport (Innovative Medicine designation) by the ...

Read more →

Democrats vote to raise drug prices

7 August 2022 - Price controls for Medicare mean higher costs for everyone else. ...

Read more →

SMC - August 2022 decisions

8 August 2022 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →

Lilly's Taltz (ixekizumab) now available in new, citrate free formulation to reduce injection site pain for improved patient experience

8 August 2022 - Since the medicine's first approval in 2016, nearly 130,000 people in the U.S. have been treated ...

Read more →

Mayne Pharma and Mithra announce FDA approval of Haloette, a generic version of Nuvaring

8 August 2022 - Mayne Pharma and Mithra Pharmaceuticals are pleased to announce that the U.S. FDA has granted approval ...

Read more →

Funding for lifesaving drug denied by B.C. health authority as couple struggles to fund their portion

7 August 2022 - Entrectinib, a targeted drug that had shown positive results in tumours that had the same gene expression, ...

Read more →

Democrats will have to limit their drug pricing reforms to Medicare to comply with Senate rules

6 August 2022 - Democrats will likely have to axe two provisions from their drug pricing plan to fit in ...

Read more →

Drug price bill pruned in Senate in partial industry win

6 August 2022 - Medicare to be allowed to negotiate drug prices for first time. ...

Read more →

Myovant Sciences and Pfizer receive U.S. FDA approval of Myfembree, a once daily treatment for the management of moderate to severe pain associated with endometriosis

5 August 2022 - Data from the Phase 3 SPIRIT program showed Myfembree reduced menstrual pain and non-menstrual pelvic pain in ...

Read more →

Australians forced to pay for methadone and other drugs to get off addictive PBS medication

7 August 2022 - Aussie taxpayers are subsidising addictive pain medication but not the treatments that help get patients off the ...

Read more →

Health insurance premiums are heading higher but by how much?

6 August 2022 - Australians are expected to pay significantly more for health insurance but talk of a double digit premium ...

Read more →

New Zealand allowed pharmacists to dispense COVID-19 antivirals and 'everyone realised it was a win'

6 August 2022 - With Australians dying from COVID-19 every day and nearly 5,000 people in hospital with the disease, experts ...

Read more →